WYNYARD
,
United Kingdom
, Oct. 27, 2017 /PRNewswire/ --
Third Quarter 2017 Highlights
- Net income of
$51 million
compared to a net loss of
$5 million
in the prior year period
- Adjusted EBITDA of
$134 million
compared to
$21 million
in the prior year period
- Diluted earnings per share of
$0.48
and adjusted diluted earnings per share of
$0.70
- Successful completion of our initial public offering ("IPO") in August 2017, and
$750 million
of new financing raised in connection with the IPO
- Favorable TiO2 industry environment for further earnings and cash flow improvement
- Net debt reduced to
$565 million
as of September 30, 2017
|
|
Three months ended |
|
Nine months ended |
|
|
September 30, |
|
June 30, |
|
September 30, |
In millions, except per share amounts |
|
2017 |
|
2016 |
|
2017 |
|
2017 |
|
2016 |
|
|
|
|
|
|
|
|
|
|
|
Revenues |
|
$ 582 |
|
$ 532 |
|
$ 562 |
|
$1,681
|
|
$1,648
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) attributable to Venator |
|
$ 51 |
|
$ (5) |
|
$ 31 |
|
$ 66 |
|
$ (81) |
Adjusted net income (loss)(1) |
|
$ 75 |
|
$ (10) |
|
$ 38 |
|
$ 121 |
|
$ (67) |
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings (loss) per share(1) |
|
$ 0.48 |
|
$ (0.05)
|
|
$ 0.29 |
|
$ 0.62 |
|
$ (0.76)
|
Adjusted diluted earnings (loss) per share(1) |
|
$ 0.70 |
|
$ (0.09)
|
|
$ 0.36 |
|
$ 1.14 |
|
$ (0.63)
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted EBITDA(1) |
|
$ 134 |
|
$ 21 |
|
$ 94 |
|
$ 277 |
|
$ 38 |
|
|
|
|
|
|
|
|
|
|
|
See end of press release for footnote explanations |
|
|
|
|
|
|
|
|
|
|
Venator Materials PLC ("Venator") (NYSE: VNTR) today reported third quarter 2017 results with net income of
$51 million
and adjusted EBITDA of
$134 million
.
Simon Turner, President and CEO of Venator, commented:
"We are encouraged by our strong sequential earnings growth in the third quarter, driven by higher price capture, our leading TiO2 position in
Europe
and the quality of our specialty TiO2 business. We also delivered further progress in our
$90 million
business improvement program. Looking forward, we believe that TiO2 industry fundamentals indicate an elongated and elevated utilization profile from which Venator is well positioned to benefit."
Segment Analysis for 3Q17 Compared to 3Q16
Titanium Dioxide
The $39 million, or 10%, increase in revenues in our Titanium Dioxide segment for the three months ended September 30, 2017 compared to the same period of 2016 was due to a 24% increase in average selling prices, partially offset by a 12% decrease in sales volumes and a 2% decrease due to product mix. The improvements in selling price consisted primarily of a 22% increase as a result of continued improvements in business conditions for TiO2, allowing for increased prices, and a 2% improvement primarily from favorable exchange rates against the Euro. Sales volumes decreased primarily as a result of the fire at our Pori,
Finland
manufacturing facility, otherwise they increased 4%.
Segment adjusted EBITDA of our Titanium Dioxide segment increased by
$105 million
for the three months ended September 30, 2017 compared to the same period in 2016 primarily as a result of an increase in revenue largely due to an increase in average selling price and an increase in volumes (excluding the impact of the Pori fire), and a $13 million reduction in costs, mainly due to our Business Improvement Program.
Performance Additives
The increase in revenues in our Performance Additives segment of $11 million, or 8%, for the three months ended September 30, 2017 compared to the same period of 2016 was due to a 3% increase in average selling price and a 5% increase in volume, partially offset by a 1% decrease due to changes in product mix. The improvement in prices was primarily in our Functional Additives product line.
Segment adjusted EBITDA in our Performance Additives segment was
$15 million
for the three month period ended September 30, 2017 compared to
$16 million
for the same period in 2016. The
$1 million
decrease is a result of higher sales volumes and higher selling prices offset by a
$2 million
decrease as a result of the release of an environmental reserve at our Hainhausen,
Germany
plant in the third quarter of 2016 and other cost increases.
Corporate and Income Taxes
Segment adjusted EBITDA for Corporate and other represented an
$8 million
loss for the third quarter 2017.
We recorded income tax expense of $14 million and income tax benefit of $7 million for the three months ended September 30, 2017 and 2016, respectively. Our tax expense is significantly affected by the mix of income and losses in tax jurisdictions in which we operate. We expect our adjusted long-term effective tax rate will be approximately 15% to 20% and our cash tax rate to be between 10 to 15%.
Update on Pori
Due to prevailing strong market conditions, our TiO2 selling prices continue to improve and our business is benefitting from the improved profitability and cash flows. This also has the effect of increasing our insurance claim for lost earnings from the Pori site. Consequently, the combination of increased TiO2 profitability and estimated reconstruction costs indicate that we will exceed our
$500 million
insurance limit. We expect to contain these over-the-limit costs within
$100
- 150 million and account for them as capital expenditures.
Prior to the fire, 60% of the site capacity produced specialty products which, on average, contributed approximately 75% of the site EBITDA. We are already running at 20% of previous capacity and we intend to restore manufacturing of the balance of these more profitable specialty products as quickly as possible in 2018. The remaining 40% of site capacity is more commoditized and may be reintroduced at a slower pace depending on market conditions, cost and projected long term return.
Liquidity and Capital Resources
As of September 30, 2017, we had cash and cash equivalents of $186 million compared with $34 million as of June 30, 2017. In addition, we have in place an undrawn asset based revolving credit facility available for our working capital needs and general corporate purposes, with a borrowing base of
$234 million
.
During the third quarter, in connection with the IPO and the separation from Huntsman Corporation, we raised $750 million of new debt, which consists of (i) $375 million of senior unsecured notes at 5.75%, due 2025, and (ii) borrowings of $375 million under our term loan facility at LIBOR plus 3%, due 2024. The net proceeds of the senior notes offering and the term loan facility were used to repay intercompany debt owed to Huntsman and to pay fees and expenses relating to the IPO and separation.
As of September 30, 2017, net debt was
$565 million
.
Earnings Conference Call Information
We will hold a conference call to discuss our third quarter financial results on Friday, October 27, 2017 at 9:00 a.m. ET.
Call-in numbers for the conference call:
U.S.
participants |
1-866-807-9684 |
International participants |
1-412-317-5415 |
In order to facilitate the registration process, you may use the following link to pre-register for the conference call. Callers who pre-register will be given a unique PIN and separate call-in number to gain immediate access to the call and bypass the live operator. To pre-register, please go to:
http://dpregister.com/10113037
Webcast Information
The conference call will be available via webcast and can be accessed from the company's website at venatorcorp.com/investor-relations.
Replay Information
The conference call will be available for replay beginning October 27, 2017 and ending November 3, 2017.
Call-in numbers for the replay:
U.S.
participants |
1-877-344-7529 |
International participants |
1-412-317-0088 |
Replay code |
10113037 |
Upcoming Conferences
During the fourth quarter, a member of management is expected to present at the Citi 2017 Basic Materials Conference on November 28, 2017. A webcast of the presentation, if applicable, along with accompanying materials will be available at venatorcorp.com/investor-relations.
Table 1 – Results of Operations
|
|
Three months ended |
|
Three months ended |
|
|
Nine months ended |
|
|
September 30, |
|
June 30, |
|
|
September 30, |
In millions, except per share amounts |
|
2017 |
|
2016 |
|
2017 |
|
|
2017 |
|
2016 |
|
|
|
|
|
|
|
|
|
|
|
|
Revenues |
|
$ 582 |
|
$ 532 |
|
$ 562 |
|
|
$ 1,681 |
|
$ 1,648 |
Cost of goods sold |
|
488 |
|
491 |
|
479 |
|
|
1,430 |
|
1,547 |
Gross profit |
|
94 |
|
41 |
|
83 |
|
|
251 |
|
101 |
Operating expenses |
|
3 |
|
33 |
|
17 |
|
|
81 |
|
135 |
Restructuring, impairment and plant closing costs |
|
16 |
|
7 |
|
7 |
|
|
49 |
|
31 |
Operating income (loss) |
|
75 |
|
1 |
|
59 |
|
|
121 |
|
(65) |
Interest expense |
|
(8) |
|
(12) |
|
(9) |
|
|
(29) |
|
(31) |
Other income |
|
- |
|
- |
|
- |
|
|
- |
|
1 |
Income (loss) before income taxes |
|
67 |
|
(11) |
|
50 |
|
|
92 |
|
(95) |
Income tax (expense) benefit |
|
(14) |
|
7 |
|
(16) |
|
|
(26) |
|
14 |
Income (loss) from continuing operations |
|
53 |
|
(4) |
|
34 |
|
|
66 |
|
(81) |
Income from discontinued operations, net of tax |
|
- |
|
2 |
|
- |
|
|
8 |
|
8 |
Net income (loss) |
|
53 |
|
(2) |
|
34 |
|
|
74 |
|
(73) |
Net income (loss) attributable to noncontrolling interests, net of tax |
|
(2) |
|
(3) |
|
(3) |
|
|
(8) |
|
(8) |
Net income (loss) attributable to Venator |
|
$ 51 |
|
$ (5) |
|
$ 31 |
|
|
$ 66 |
|
$ (81) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted EBITDA(1) |
|
$ 134 |
|
$ 21 |
|
$ 94 |
|
|
$ 277 |
|
$ 38 |
Adjusted net income(1) |
|
$ 75 |
|
$ (10) |
|
$ 38 |
|
|
$ 121 |
|
$ (67) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic earnings (losses) per share(1) |
|
$ 0.48 |
|
$ (0.05) |
|
$ 0.29 |
|
|
$ 0.63 |
|
$ (0.76) |
Diluted earnings (losses) per share(1) |
|
$ 0.48 |
|
$ (0.05) |
|
$ 0.29 |
|
|
$ 0.62 |
|
$ (0.76) |
Adjusted earnings (losses) per share(1) |
|
$ 0.71 |
|
$ (0.09) |
|
$ 0.36 |
|
|
$ 1.14 |
|
$ (0.63) |
Adjusted diluted earnings (losses) per share(1) |
|
$ 0.70 |
|
$ (0.09) |
|
$ 0.36 |
|
|
$ 1.14 |
|
$ (0.63) |
|
|
|
|
|
|
|
|
|
|
|
|
Common share information(1): |
|
|
|
|
|
|
|
|
|
|
|
Basic shares outstanding |
|
106.3 |
|
106.3 |
|
106.3 |
|
|
106.3 |
|
106.3 |
Diluted shares |
|
106.6 |
|
106.3 |
|
106.3 |
|
|
106.6 |
|
106.3 |
Diluted shares for adjusted diluted income per share |
|
106.6 |
|
106.3 |
|
106.3 |
|
|
106.6 |
|
106.3 |
|
|
|
|
|
|
|
|
|
|
|
|
See end of press release for footnote explanations |
|
|
|
|
|
|
|
Table 2 – Results of Operations by Segment
|
|
Three months ended |
|
Three months ended |
|
Nine months ended |
|
|
|
|
September 30, |
|
Better / |
|
June 30, |
|
Better / |
|
September 30, |
|
Better / |
In millions |
|
2017 |
|
2016 |
|
(Worse) |
|
2017 |
|
(Worse) |
|
2017 |
|
2016 |
|
(Worse) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Segment Revenues: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Titanium Dioxide |
|
$ 431 |
|
$ 392 |
|
10% |
|
$ 401 |
|
7% |
|
$ 1,217 |
|
$ 1,197 |
|
2% |
Performance Additives |
|
151 |
|
140 |
|
8% |
|
161 |
|
(6)% |
|
464 |
|
451 |
|
3% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ 582 |
|
$ 532 |
|
9% |
|
$ 562 |
|
4% |
|
$ 1,681 |
|
$ 1,648 |
|
2% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Segment Adjusted EBITDA(1): |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Titanium Dioxide |
|
$ 127 |
|
$ 22 |
|
477% |
|
$ 93 |
|
37% |
|
$ 268 |
|
$ 28 |
|
857% |
Performance Additives |
|
15 |
|
16 |
|
(6)% |
|
21 |
|
(29)% |
|
57 |
|
56 |
|
2% |
Corporate and other |
|
(8) |
|
(17) |
|
53% |
|
(20) |
|
60% |
|
(48) |
|
(46) |
|
(4)% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ 134 |
|
$ 21 |
|
538% |
|
$ 94 |
|
43% |
|
$ 277 |
|
$ 38 |
|
629% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See end of press release for footnote explanations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Table 3 – Factors Impacting Sales Revenue
|
|
Three months ended |
|
|
September 30, 2017 vs. 2016 |
|
|
Average Selling Price(a) |
|
|
|
|
|
|
|
|
Local |
|
Exchange |
|
Sales Mix |
|
Sales |
|
|
|
|
Currency |
|
Rate |
|
& Other |
|
Volume(b) |
|
Total |
|
|
|
|
|
|
|
|
|
|
|
Titanium Dioxide |
|
22% |
|
2% |
|
(2)% |
|
(12)%(c) |
|
22% |
Performance Additives |
|
2% |
|
1% |
|
(1)% |
|
5% |
|
7% |
Total Company |
|
15% |
|
2% |
|
(1)% |
|
(7)% |
|
9% |
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine months ended |
|
|
September 30, 2017 vs. 2016 |
|
|
Average Selling Price(a) |
|
|
|
|
|
|
|
|
Local |
|
Exchange |
|
Sales Mix |
|
Sales |
|
|
|
|
Currency |
|
Rate |
|
& Other |
|
Volume(b) |
|
Total |
|
|
|
|
|
|
|
|
|
|
|
Titanium Dioxide |
|
17% |
|
(1)% |
|
(1)% |
|
(13)%(d) |
|
15% |
Performance Additives |
|
1% |
|
(1)% |
|
0% |
|
2% |
|
2% |
Total Company |
|
12% |
|
(1)% |
|
(1)% |
|
(8)% |
|
2% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Table 4 – Reconciliation of
U.S.
GAAP to Non-GAAP Measures
|
|
|
|
|
|
Income Tax |
|
|
|
|
|
Diluted Earnings (Loss) |
|
|
EBITDA |
|
(Expense) Benefit(2) |
|
Net Income (Loss) |
|
Per Share(1) |
|
|
Three months ended |
|
Three months ended |
|
Three months ended |
|
Three months ended |
|
|
September 30, |
|
September 30, |
|
September 30, |
|
September 30, |
In millions, except per share amounts |
|
2017 |
|
2016 |
|
2017 |
|
2016 |
|
2017 |
|
2016 |
|
2017 |
|
2016 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) |
|
$ 53 |
|
$ (2) |
|
|
|
|
|
$ 53 |
|
$ (2) |
|
$ 0.50 |
|
$ (0.02) |
Net income attributable to noncontrolling interests |
|
(2) |
|
(3) |
|
|
|
|
|
(2) |
|
(3) |
|
(0.02) |
|
(0.03) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) attributable to Venator |
|
51 |
|
(5) |
|
|
|
|
|
51 |
|
(5) |
|
0.48 |
|
(0.05) |
Interest expense |
|
8 |
|
12 |
|
|
|
|
|
|
|
|
|
|
|
|
Income tax expense (benefit) from continuing operations |
|
14 |
|
(7) |
|
(14) |
|
7 |
|
|
|
|
|
|
|
|
Depreciation and amortization |
|
35 |
|
30 |
|
|
|
|
|
|
|
|
|
|
|
|
Business acquisition and integration expenses |
|
4 |
|
3 |
|
(1) |
|
- |
|
3 |
|
3 |
|
0.03 |
|
0.03 |
Income from discontinued operations |
|
- |
|
(2) |
|
N/A |
|
N/A |
|
- |
|
(2) |
|
- |
|
(0.02) |
Gain on disposition of businesses/assets |
|
- |
|
(23) |
|
- |
|
6 |
|
- |
|
(17) |
|
- |
|
(0.16) |
Net plant incident costs |
|
1 |
|
3 |
|
- |
|
(1) |
|
1 |
|
2 |
|
0.01 |
|
0.02 |
Amortization of pension and postretirement actuarial losses |
|
5 |
|
3 |
|
- |
|
- |
|
5 |
|
3 |
|
0.05 |
|
0.03 |
Restructuring, impairment and plant closing costs |
|
16 |
|
7 |
|
(1) |
|
(1) |
|
15 |
|
6 |
|
0.14 |
|
0.06 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted(1) |
|
$ 134 |
|
$ 21 |
|
$ (16) |
|
$ 11 |
|
$ 75 |
|
$ (10) |
|
$ 0.70 |
|
$ (0.09) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted income tax expense (benefit)(1) |
|
|
|
|
|
|
|
|
|
$ 16 |
|
$ (11) |
|
|
|
|
Net income attributable to noncontrolling interests, net of tax |
|
|
|
|
|
|
|
|
|
2 |
|
3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted pre-tax income (loss)(1) |
|
|
|
|
|
|
|
|
|
$ 93 |
|
$ (18) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted effective tax rate |
|
|
|
|
|
|
|
|
|
17% |
|
61% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income Tax |
|
|
|
|
|
Diluted Earnings (Loss) |
|
|
EBITDA |
|
(Expense) Benefit(2) |
|
Net Income |
|
Per Share(1) |
|
|
Three months ended |
|
Three months ended |
|
Three months ended |
|
Three months ended |
|
|
June 30, |
|
June 30, |
|
June 30, |
|
June 30, |
In millions, except per share amounts |
|
2017 |
|
2017 |
|
2017 |
|
2017 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ 34 |
|
|
|
|
|
|
|
$ 34 |
|
|
|
$ 0.32 |
|
|
Net income attributable to noncontrolling interests |
|
(3) |
|
|
|
|
|
|
|
(3) |
|
|
|
(0.03) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income attributable to Venator |
|
31 |
|
|
|
|
|
|
|
31 |
|
|
|
0.29 |
|
|
Interest expense |
|
9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income tax expense from continuing operations |
|
16 |
|
|
|
(16) |
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization |
|
29 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net plant incident costs (credits) |
|
(2) |
|
|
|
- |
|
|
|
(2) |
|
|
|
(0.02) |
|
|
Amortization of pension and postretirement actuarial losses |
|
4 |
|
|
|
- |
|
|
|
4 |
|
|
|
0.04 |
|
|
Restructuring, impairment and plant closing costs |
|
7 |
|
|
|
(2) |
|
|
|
5 |
|
|
|
0.05 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted(1) |
|
$ 94 |
|
|
|
$ (18) |
|
|
|
$ 38 |
|
|
|
$ 0.36 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted income tax expense(1) |
|
|
|
|
|
|
|
|
|
$ 18 |
|
|
|
|
|
|
Net income attributable to noncontrolling interests, net of tax |
|
|
|
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted pre-tax income(1) |
|
|
|
|
|
|
|
|
|
$ 59 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted effective tax rate |
|
|
|
|
|
|
|
|
|
31% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income Tax |
|
|
|
|
|
Diluted Earnings (Loss) |
|
|
EBITDA |
|
(Expense) Benefit(2) |
|
Net Income (Loss) |
|
Per Share(1) |
|
|
Nine months ended |
|
Nine months ended |
|
Nine months ended |
|
Nine months ended |
|
|
September 30, |
|
September 30, |
|
September 30, |
|
September 30, |
In millions, except per share amounts |
|
2017 |
|
2016 |
|
2017 |
|
2016 |
|
2017 |
|
2016 |
|
2017 |
|
2016 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) |
|
$ 74 |
|
$ (73) |
|
|
|
|
|
$ 74 |
|
$ (73) |
|
$ 0.70 |
|
$ (0.69) |
Net income attributable to noncontrolling interests |
|
(8) |
|
(8) |
|
|
|
|
|
(8) |
|
(8) |
|
(0.08) |
|
(0.08) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) attributable to Venator |
|
66 |
|
(81) |
|
|
|
|
|
66 |
|
(81) |
|
0.62 |
|
(0.76) |
Interest expense |
|
29 |
|
31 |
|
|
|
|
|
|
|
|
|
|
|
|
Income tax expense (benefit) from continuing operations |
|
26 |
|
(14) |
|
(26) |
|
14 |
|
|
|
|
|
|
|
|
Income tax benefit from discontinued operations |
|
3 |
|
2 |
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization |
|
95 |
|
84 |
|
|
|
|
|
|
|
|
|
|
|
|
Business acquisition and integration expenses |
|
2 |
|
11 |
|
(1) |
|
(5) |
|
1 |
|
6 |
|
0.01 |
|
0.06 |
Income from discontinued operations |
|
(11) |
|
(10) |
|
N/A |
|
N/A |
|
(8) |
|
(8) |
|
(0.08) |
|
(0.08) |
Gain on disposition of businesses/assets |
|
- |
|
(23) |
|
- |
|
6 |
|
- |
|
(17) |
|
- |
|
(0.16) |
Certain legal settlements and related expenses |
|
1 |
|
1 |
|
- |
|
- |
|
1 |
|
1 |
|
0.01 |
|
0.01 |
Net plant incident costs (credits) |
|
4 |
|
(2) |
|
(1) |
|
- |
|
3 |
|
(2) |
|
0.03 |
|
(0.02) |
Amortization of pension and postretirement actuarial losses |
|
13 |
|
8 |
|
- |
|
1 |
|
13 |
|
9 |
|
0.12 |
|
0.08 |
Restructuring, impairment and plant closing costs |
|
49 |
|
31 |
|
(4) |
|
(6) |
|
45 |
|
25 |
|
0.42 |
|
0.24 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted(1) |
|
$ 277 |
|
$ 38 |
|
$ (32) |
|
$ 10 |
|
$ 121 |
|
$ (67) |
|
$ 1.14 |
|
$ (0.63) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted income tax expense (benefit)(1) |
|
|
|
|
|
|
|
|
|
$ 32 |
|
$ (10) |
|
|
|
|
Net income attributable to noncontrolling interests, net of tax |
|
|
|
|
|
|
|
|
|
8 |
|
8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted pre-tax income (loss)(1) |
|
|
|
|
|
|
|
|
|
$ 161 |
|
$ (69) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted effective tax rate |
|
|
|
|
|
|
|
|
|
20% |
|
14% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See end of press release for footnote explanations |
|
|
|
|
|
|
|
|
|
|
|
|
|
Table 5 – Selected Balance Sheet Items
|
|
September 30, |
|
June 30, |
|
December 31, |
In millions |
|
2017 |
|
2017 |
|
2016 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash |
|
$ 186 |
|
$ 34 |
|
$ 29 |
Accounts and notes receivable, net |
|
420 |
|
602 |
|
490 |
Inventories |
|
431 |
|
431 |
|
426 |
Prepaid and other current assets |
|
84 |
|
77 |
|
154 |
Property, plant and equipment, net |
|
1,264 |
|
1,189 |
|
1,178 |
Other assets |
|
339 |
|
344 |
|
384 |
|
|
|
|
|
|
|
Total assets |
|
$ 2,724 |
|
$ 2,677 |
|
$ 2,661 |
|
|
|
|
|
|
|
Accounts payable |
|
$ 345 |
|
$ 921 |
|
$ 992 |
Other current liabilities |
|
213 |
|
211 |
|
173 |
Current portion of debt |
|
4 |
|
3 |
|
10 |
Long-term debt |
|
747 |
|
11 |
|
13 |
Long-term debt to affiliates |
|
- |
|
90 |
|
882 |
Non-current payable to affiliates |
|
73 |
|
- |
|
- |
Other liabilities |
|
337 |
|
336 |
|
414 |
|
|
|
|
|
|
|
Total equity |
|
1,005 |
|
1,105 |
|
177 |
|
|
|
|
|
|
|
Total liabilities and equity |
|
$ 2,724 |
|
$ 2,677 |
|
$ 2,661 |
Table 6 – Outstanding Debt
|
|
September 30, |
|
December 31, |
In millions |
|
2017 |
|
2016 |
|
|
|
|
|
|
|
|
|
|
Debt: |
|
|
|
|
Term loan facility |
|
$ 370 |
|
$ - |
Senior notes |
|
368 |
|
- |
Amounts outstanding under A/R programmes |
|
- |
|
106 |
Variable interest entities |
|
2 |
|
2 |
Other debt |
|
11 |
|
21 |
|
|
|
|
|
Total debt - excluding affiliates |
|
751 |
|
129 |
|
|
|
|
|
Total cash |
|
186 |
|
29 |
|
|
|
|
|
Net debt- excluding affiliates |
|
$ 565 |
|
$ 100 |
Footnotes
About Venator
Venator is a global manufacturer and marketer of chemical products that comprise a broad range of pigments and additives that bring color and vibrancy to buildings, protect and extend product life, and reduce energy consumption. We market our products globally to a diversified group of industrial customers through two segments: Titanium Dioxide, which consists of our TiO2 business, and Performance Additives, which consists of our functional additives, color pigments, timber treatment and water treatment businesses. We operate 27 facilities, employ approximately 4,500 associates worldwide and sell our products in more than 110 countries.
Social Media:
Twitter: www.twitter.com/VenatorCorp
Facebook: www.facebook.com/venatorcorp
LinkedIn: www.linkedin.com/company/venator-corp
Cautionary Statement Concerning Forward-Looking Statements
Certain statements contained in this press release constitute "forward-looking statements" within the meaning of the
U.S.
Private Securities Litigation Reform Act of 1995. These forward-looking statements represent Venator's expectations or beliefs concerning future events, and it is possible that the expected results described in this press release will not be achieved. These forward-looking statements are subject to risks, uncertainties and other factors, many of which are outside of Venator's control, that could cause actual results to differ materially from the results discussed in the forward-looking statements, including any delays in reconstruction of our Pori,
Finland
manufacturing facility or losses for business interruption or construction costs that exceed our coverage limit applicable to the fire at that facility.
Any forward-looking statement speaks only as of the date on which it is made, and, except as required by law, Venator does not undertake any obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise. New factors emerge from time to time, and it is not possible for Venator to predict all such factors. When considering these forward-looking statements, you should keep in mind the risk factors and other cautionary statements in the prospectus filed with the SEC in connection with Venator's initial public offering. The risk factors and other factors noted in Venator's prospectus could cause its actual results to differ materially from those contained in any forward-looking statement.
View original content with multimedia:http://www.prnewswire.com/news-releases/venator-announces-third-quarter-2017-results-reports-strong-sequential-earnings-growth-300544721.html
SOURCE Venator Materials PLC